Healios KK (4593) Stock Price & News

Why is 4593 down 2.52%?

Dive Deeper

4593:TYO

Healios KK

¥310.00

-2.52%

(-8.00) 1D

Oct 7, 10:46:52 AM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4593...

Open

¥313

High

¥318

Low

¥309

Mkt. cap

42.02B

Avg. vol.

1.82M

Volume

885.00K

P/E ratio

111.61

52-wk high

¥531

52-wk low

¥208

EPS

¥3

Shares outstanding

49.25M

No. of employees

Open

¥313

High

¥318

Low

¥309

Mkt. cap

42.02B

Avg. vol.

1.82M

Volume

885.00K

P/E ratio

111.61

52-wk high

¥531

52-wk low

¥208

EPS

¥3

Shares outstanding

49.25M

No. of employees

Related stocks

4506

Sumitomo Pharma Co Ltd

¥1,616.00

-0.31%

4594

BrightPath Biotherapeutics Co Ltd

News stories

From web sources and news partners

VT Markets

7 minutes ago

S&P 500 futures test 7,800 as AI rally persists amid bearish retail sentiment and macro headwinds

BigGo Finance

37 minutes ago

S&P 500 and Nasdaq Close at Record Highs; Google Nuclear Power Deal Ignites Utilities Sector

富途牛牛

44 minutes ago

10-year U.S. Treasury yields surge to 5.3%, while the Nasdaq and S&P 500 hit new highs—how should we interpret this unusual equity-bond dynamic?

RFI

4 hours ago

US stocks hit fresh records as oil stabilizes on rising supplies

About Healios KK

CEOHardy TS Kagimoto

Employees75

FoundedFeb 24, 2011

Headquarters-

SectorBiotechnology

Websitehealios.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	19.00M	25.00M	8.00M	7.00M
Cost of goods sold	45.00M	76.00M	-	-
Cost of revenue	45.00M	76.00M	-	-
Research and development expenses	467.00M	491.00M	798.00M	935.00M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	271.00M	460.00M	354.00M	348.00M
Operating expense	733.00M	950.00M	1.14B	1.28B
Total operating expenses	778.00M	1.03B	1.14B	1.28B
Operating income	-759.00M	-1.00B	-1.13B	-1.27B
Other non operating income	-	905.00M	-1.00M	1.00M
EBT including unusual items	569.00M	2.01B	-3.46B	1.19B
EBT excluding unusual items	569.00M	1.67B	-3.46B	1.19B
Income tax expense	6.00M	91.00M	-7.00M	-5.00M
Effective tax rate	1.05%	4.53%	0.20%	-0.42%
Other operating expenses	-5.00M	-10.00M	-14.00M	-3.00M
Net income	564.00M	1.93B	-3.48B	1.19B
Net profit margin	2,968.42%	7,716.00%	-43,475.00%	17,028.57%
Earnings per share	-	-	-	-
Interest and investment income	1.33B	2.51B	326.00M	2.46B
Interest expense	-	-717.00M	-2.66B	-
Net interest expenses	1.33B	1.79B	-2.33B	2.46B
Depreciation and amortization charges	-	9.00M	-	-
EBITDA	-691.00M	-929.00M	-1.06B	-1.20B
Gain or loss from assets sale	-	-	-	-

Ask anything